Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Robert S, Makar"'
Autor:
Zhihui Zhang, Wei Hong, Qian Wu, Spiridon Tsavachidis, Jian-rong Li, Christopher I. Amos, Chao Cheng, Sarah E. Sartain, Vahid Afshar-Kharghan, Jing-fei Dong, Pavan Bhatraju, Paul J. Martin, Robert S. Makar, Pavan K. Bendapudi, Ang Li
Publikováno v:
Thrombosis Research. 225:39-46
Publikováno v:
Transfusion. 63:745-754
Autor:
Brody Foy, Jonathan Stefely, Pavan K Bendapudi, Robert P. Hasserjian, Hanny Al-Samkari, Abner Louissaint, Megan Fitzpatrick, Bailey Hutchison, Christopher Mow, Julia Collins, Hasmukh Patel, Chhaya Patel, Nikita Patel, Samantha Ho, Richard M Kaufman, Walter 'Sunny' Dzik, John M Higgins, Robert S Makar
Publikováno v:
Blood Advances.
Examination of red blood cell (RBC) morphology in peripheral blood smears can help diagnose hematologic disease, even in resource-limited settings, but this analysis remains subjective and semi-quantitative with low throughput. Prior attempts to deve
Autor:
Brody Foy, Jonathan Stefely, Pavan K. Bendapudi, Robert P. Hasserjian, Hanny Al-Samkari, Abner Louissaint, Megan J Fitzpatrick, Bailey Hutchison, Christopher Mow, Julia Collins, Hasmukh P. Patel, Chhaya Patel, Nikita Patel, Samantha Ho, Richard M Kaufman, Walter Dzik, John M. Higgins, Robert S Makar
Publikováno v:
Blood. 140:10704-10705
Autor:
Christoph Gasteyger, Miguel G Uriol-Rivera, Ana I Ávila, Robert S Makar, Frank R Ernst, John N Booth III, Angels Comas, Ching Lum, Ioannis Tomazos, Yan Wang, Pavan K. Bendapudi
Publikováno v:
Blood. 140:2780-2781
Publikováno v:
Transfusion. 61:537-545
Background Therapeutic plasma exchange (TPE) is often used to decrease serum triglyceride levels in hypertriglyceridemic pancreatitis (HTGP), although there is a lack of high-quality data directly attributing improved clinical outcomes to TPE. There
Autor:
Robert S. Makar, Roger Belizaire
Publikováno v:
Transfusion Medicine Reviews
Refractoriness to platelet transfusion is a common clinical problem encountered by the transfusion medicine specialist. It is well recognized that most causes of refractoriness to platelet transfusion are not a consequence of alloimmunization to huma
Autor:
Lova Sun, Lynne Uhl, Pavan K. Bendapudi, Ang Li, Walter H. Dzik, Richard M. Kaufman, Christopher P. Stowell, Justine H. Ryu, Robert S. Makar, Meaghan E. Colling, Vivek A. Upadhyay
Publikováno v:
Transfusion. 60:841-846
BACKGROUND The introduction of therapeutic plasma exchange (TPE) dramatically decreased mortality in patients with immune thrombotic thrombocytopenic purpura (iTTP). However, there are few modern descriptions of residual causes of death from iTTP and
Autor:
Mona Papari, Richard M. Kaufman, Rachel A. Gaufberg, Donna Neuberg, John M. Gansner, Jake Goldstein, Robert S. Makar
Publikováno v:
Transfusion. 59:2783-2787
Background In a recent study, we determined that 30% of frequent plateletpheresis donors collected using the Trima Accel Automated Blood Collection System (Terumo BCT) had a CD4+ T-cell count below 200 cells/μL. Whether CD4+ T-cell lymphopenia is as
Autor:
Justine H. Ryu, Robert S. Makar, Lynne Uhl, Richard M. Kaufman, Johnathan P. Mack, Christopher P. Stowell, Ang Li, Pavan K. Bendapudi, Walter Sunny Dzik, Vivek A. Upadhyay, Lova Sun
Publikováno v:
Blood Advances. 3:1512-1518
Patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP) often experience life-threatening relapses of the disease, and rituximab (RTX) can be used to mitigate relapse risk. However, the predictors of relapse in iTTP and the magnitude